Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cytomed Therapeutics Ltd (GDTC) since 2026 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Cytomed Therapeutics Ltd. Table 2 shows the detailed insider transactions. This company's CIK number is 1873093.
Total stock buying since 2026: $128,799.
Total stock sales since 2026: $0.
Total stock option exercises since 2026: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2026 | 112,000 | $128,799 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2026-05 | 112,000 | $128,799 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-05-13 | Choo Chee Kong | Buy | 112,000 | 1.15 | 128,799 |
Insider trading activities including stock purchases, stock sales, and option exercises of GDTC listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Cytomed Therapeutics Ltd (symbol GDTC, CIK number 1873093) see the Securities and Exchange Commission (SEC) website.